FDA May Emerge From Zohydro Approval Purgatory in October
This article was originally published in RPM Report
Executive Summary
FDA could get relief this autumn from a year of political controversy stemming from the approval of Zohydro, thanks to two abuse-deterrent hydrocodone applications in the works from Purdue and Zogenix.